Insider · CIK 0001861656
Corbin Barnes
Files at IOSP (INNOSPEC INC.). First filing Jan 30, 2025, latest Feb 26, 2025.
In brief
Corbin Barnes files SEC Form 4 as officer at IOSP (INNOSPEC INC.). Since Jan 30, 2025, Corbin Barnes has reported 0 open-market buys worth $0 and 3 open-market sells worth $376k, the latest filed on Feb 26, 2025.
A track record needs three past buys with six months of prices behind them; Corbin Barnes has 0, so none is measured yet.
The newest scored trade: sold $62k of IOSP on Feb 24, 2025, filed Feb 26, 2025, scored 22 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IOSP: INNOSPEC INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | INNOSPEC INC. | $62k 598 shares | -7% | - | |
| 54Moderate | INNOSPEC INC. | $278k 2,692 shares | -25% | - | |
| 36Weak | INNOSPEC INC. | $36k 307 shares | -4% | - |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | IOSP INNOSPEC INC. | AGrant or award Phantom Stockderivative | +2,642 | $0.00 | $0 | 2,642 | 8 d ago |
| Feb 27, 2026 | IOSP INNOSPEC INC. | FTax withholding Common Stock | -166 | $78.34 | $13k | 13,080 | Mar 3, 2026 |
| Feb 23, 2026 | IOSP INNOSPEC INC. | AGrant or award Common Stock | +2,481 | $0.00 | $0 | 13,246 | Feb 25, 2026 |
| Feb 16, 2026 | IOSP INNOSPEC INC. | AGrant or award Common Stock | +1,730 | $0.00 | $0 | 10,765 | Feb 18, 2026 |
| May 13, 2025 | IOSP INNOSPEC INC. | FTax withholding Common Stock | -740 | $91.53 | $68k | 8,998 | May 15, 2025 |
| Feb 21, 2025 | IOSP INNOSPEC INC. | MOption exercise Common Stock | +200 | $99.68 | $20k | 8,251 | Feb 27, 2025 |
| Feb 21, 2025 | IOSP INNOSPEC INC. | DDisposition to issuer Common Stock | -200 | $101.99 | $20k | 8,051 | Feb 27, 2025 |
| Feb 24, 2025 | IOSP INNOSPEC INC. | AGrant or award Common Stock | +1,687 | $0.00 | $0 | 9,738 | Feb 27, 2025 |
| Feb 21, 2025 | IOSP INNOSPEC INC. | MOption exercise Stock Appreciation Rightderivative | -200 | $0.00 | $0 | 0 | Feb 27, 2025 |
| Feb 24, 2025 | IOSP INNOSPEC INC. | MOption exercise Common Stock | +598 | $99.68 | $60k | 8,649 | Feb 26, 2025 |
| Feb 24, 2025 | IOSP INNOSPEC INC. | SOpen-market sale Common Stock | -598 | $103.06 | $62k | 8,051 | Feb 26, 2025 |
| Feb 24, 2025 | IOSP INNOSPEC INC. | MOption exercise Employee Stock Optionderivative | -598 | $0.00 | $0 | 0 | Feb 26, 2025 |
| Feb 21, 2025 | IOSP INNOSPEC INC. | AGrant or award Common Stock | +2,692 | $0.00 | $0 | 10,743 | Feb 24, 2025 |
| Feb 21, 2025 | IOSP INNOSPEC INC. | SOpen-market sale Common Stock | -2,692 | $103.30 | $278k | 8,051 | Feb 24, 2025 |
| Nov 18, 2024 | IOSP INNOSPEC INC. | SOpen-market sale Common Stock | -307 | $117.52 | $36k | 8,051 | Jan 30, 2025 |
Questions about Corbin Barnes
Answered from the filings on this page, as of the latest one.
Is Corbin Barnes buying or selling?
Not in the last 12 months. Corbin Barnes's latest open-market trade on SEC Form 4 was sold $62k of IOSP on Feb 24, 2025.
How did Corbin Barnes's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Corbin Barnes has 0.
Where does Corbin Barnes file Form 4?
Corbin Barnes has filed Form 4 at IOSP (INNOSPEC INC.) as SVP, Corporate Dev and IR. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.